Complexity of progranulin mechanisms of action in mesothelioma
Abstract Background Mesothelioma is an aggressive disease with limited therapeutic options. The growth factor progranulin plays a critical role in several cancer models, where it regulates tumor initiation and progression. Recent data from our laboratories have demonstrated that progranulin and its...
Main Authors: | Elisa Ventura, Christopher Xie, Simone Buraschi, Antonino Belfiore, Renato V. Iozzo, Antonio Giordano, Andrea Morrione |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-12-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-022-02546-4 |
Similar Items
-
Progranulin Oncogenic Network in Solid Tumors
by: Elisa Ventura, et al.
Published: (2023-03-01) -
EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?
by: Mario Cioce, et al.
Published: (2021-02-01) -
Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction
by: Maki Murakoshi, et al.
Published: (2022-12-01) -
The Role of the Eph Receptor Family in Tumorigenesis
by: Meg Anderton, et al.
Published: (2021-01-01) -
EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer
by: Robiya Joseph, et al.
Published: (2024-01-01)